- Home
- SST vs PASG Comparison
SST vs PASG Comparison
Compare SST & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- PASG
- Stock Information
- Founded
- SST 2013
- PASG 2017
- Country
- SST United States
- PASG United States
- Employees
- SST N/A
- PASG N/A
- Industry
- SST Diversified Commercial Services
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- PASG Health Care
- Exchange
- SST Nasdaq
- PASG Nasdaq
- Market Cap
- SST 23.3M
- PASG 20.3M
- IPO Year
- SST N/A
- PASG 2020
- Fundamental
- Price
- SST $5.74
- PASG $6.01
- Analyst Decision
- SST Strong Buy
- PASG Strong Buy
- Analyst Count
- SST 1
- PASG 3
- Target Price
- SST $10.00
- PASG $153.33
- AVG Volume (30 Days)
- SST 59.2K
- PASG 99.1K
- Earning Date
- SST 08-07-2025
- PASG 08-19-2025
- Dividend Yield
- SST N/A
- PASG N/A
- EPS Growth
- SST N/A
- PASG N/A
- EPS
- SST N/A
- PASG N/A
- Revenue
- SST $317,055,000.00
- PASG N/A
- Revenue This Year
- SST N/A
- PASG N/A
- Revenue Next Year
- SST $8.39
- PASG N/A
- P/E Ratio
- SST N/A
- PASG N/A
- Revenue Growth
- SST N/A
- PASG N/A
- 52 Week Low
- SST $2.90
- PASG $5.12
- 52 Week High
- SST $15.30
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- SST 44.70
- PASG 46.97
- Support Level
- SST $4.95
- PASG $5.41
- Resistance Level
- SST $6.31
- PASG $6.27
- Average True Range (ATR)
- SST 0.70
- PASG 0.60
- MACD
- SST -0.18
- PASG 0.04
- Stochastic Oscillator
- SST 23.06
- PASG 30.77
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.